Skip to main content
SpringerLink
Log in

Successful treatment by CAR T-cells in multi-refractory mantle cell lymphoma with central nervous system involvement

  • Letter to the Editor
  • Published:
Annals of Hematology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Data availability

The data that support the findings of this manuscript are available on request from the corresponding author.

References

  1. Cheah CY, George A, Giné E et al (2013) Central nervous system involvement in mantle cell lymphoma: clinical features, prognostic factors and outcomes from the European Mantle Cell Lymphoma Network. Ann Oncol Off J Eur Soc Med Oncol 24:2119–2123. https://doi.org/10.1093/annonc/mdt139

    Article  CAS  Google Scholar 

  2. Kaji FA, Martinez-Calle N, Sovani V, Fox CP (2022) Rare central nervous system lymphomas. Br J Haematol 197:662–678. https://doi.org/10.1111/bjh.18128

    Article  PubMed  PubMed Central  Google Scholar 

  3. Eyre TA, Cheah CY, Wang ML (2022) Therapeutic options for relapsed/refractory mantle cell lymphoma. Blood 139:666–677. https://doi.org/10.1182/blood.2021013326

    Article  CAS  PubMed  Google Scholar 

  4. Wang M, Munoz J, Goy A et al (2020) KTE-X19 CAR T-Cell therapy in relapsed or refractory mantle-cell lymphoma. N Engl J Med 382:1331–1342. https://doi.org/10.1056/NEJMoa1914347

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  5. Wang Y, Jain P, Locke FL et al (2023) Brexucabtagene autoleucel for relapsed or refractory mantle cell lymphoma in standard-of-care practice: results from the US lymphoma CAR T consortium. J Clin Oncol Off J Am Soc Clin Oncol 41:2594–2606. https://doi.org/10.1200/JCO.22.01797

    Article  CAS  Google Scholar 

  6. Siddiqi T, Wang X, Blanchard MS et al (2021) CD19-directed CAR T-cell therapy for treatment of primary CNS lymphoma. Blood Adv 5:4059–4063. https://doi.org/10.1182/bloodadvances.2020004106

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  7. Alcantara M, Houillier C, Blonski M et al (2022) CAR T-cell therapy in primary central nervous system lymphoma: the clinical experience of the French LOC network. Blood 139:792–796. https://doi.org/10.1182/blood.2021012932

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  8. Frigault MJ, Dietrich J, Gallagher K et al (2022) Safety and efficacy of tisagenlecleucel in primary CNS lymphoma: a phase 1/2 clinical trial. Blood 139:2306–2315. https://doi.org/10.1182/blood.2021014738

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. Vu K, Frank MJ (2023) CAR T-cell therapy for mantle cell lymphoma with central nervous system relapse. Blood Adv 7:375–378. https://doi.org/10.1182/bloodadvances.2022008031

    Article  CAS  PubMed  Google Scholar 

  10. Corneau A, Parizot C, Cherai M et al (2021) Mass cytometry: a robust platform for the comprehensive immunomonitoring of CAR-T-cell therapies. Br J Haematol 194:788–792. https://doi.org/10.1111/bjh.17551

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Service d’Hématologie Clinique, Hôpital Pitié-Salpêtrière, AP-HP, Sorbonne Université, 47-83 Bd de l’Hôpital 75651, Paris Cedex, France

    Adrien Caillet, Madalina Uzunov, Valérie Friser, Nabih Azar, Marine Baron, Xavier Phina-Ziebin, Sylvain Choquet & Damien Roos-Weil

  2. IHU, ICM, Neurology, Groupe Hospitalier Pitié-Salpêtrière, AP-HP, Sorbonne Université, Paris, France

    Caroline Houillier & Monica Ribeiro

  3. Service d’Hématologie Biologique, Hôpital Pitié-Salpêtrière, AP-HP, Sorbonne Université, Paris, France

    Elise Sourdeau

  4. Department of Immunology, Assistance Publique-Hôpitaux de Paris (AP-HP), Hôpital Pitié-Salpêtrière, Paris, France

    Marianne Gazzano

  5. Neuroradiology Unit, Assistance Publique-Hôpitaux de Paris (AP-HP), Hôpital Pitié-Salpêtrière, Paris, France

    Lucia Nicelli

Authors
  1. Adrien Caillet
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Caroline Houillier
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Elise Sourdeau
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Marianne Gazzano
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Madalina Uzunov
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Valérie Friser
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Monica Ribeiro
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Lucia Nicelli
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Nabih Azar
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Marine Baron
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. Xavier Phina-Ziebin
    View author publications

    You can also search for this author in PubMed Google Scholar

  12. Sylvain Choquet
    View author publications

    You can also search for this author in PubMed Google Scholar

  13. Damien Roos-Weil
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

AC, CH, ES, MG, MU, VF, MR, LN, NA, MB, XP, SC, and DR-W performed and analyzed the data. AC, CH, SC, and DR-W designed the research study. AC and DR-W wrote the paper. All co-authors reviewed and edited the manuscript.

Corresponding author

Correspondence to Damien Roos-Weil.

Ethics declarations

Ethics approval and consent to participate

Not applicable.

Consent for publication

Informed consent for publication was obtained from all individual participants included in the study.

Conflict of interest

The authors declare no competing interests.

Additional information

Publisher's note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

Below is the link to the electronic supplementary material.

Supplementary file1 (DOCX 12 KB)

Supplementary file2 (PPTX 77 KB)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Caillet, A., Houillier, C., Sourdeau, E. et al. Successful treatment by CAR T-cells in multi-refractory mantle cell lymphoma with central nervous system involvement. Ann Hematol 102, 3295–3297 (2023). https://doi.org/10.1007/s00277-023-05408-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00277-023-05408-x

Keywords

Search

Navigation